Completed OBSERVATIONAL NCT06210139

Pharmacotherapy Prescribing Pattern and the Adherence Level to Iron Chelation Therapy in Thalassemia

Evaluating the Prescribing Pattern and Knowledge, Attitude and Practice as Well as the Adherence Level to Iron Chelation Therapy in Thalassemia

Sponsor: Reem Ali Shaker

Conditions Thalassemia

Updated 4 times since 2024 Last updated: Jul 19, 2024 Started: Mar 28, 2023 Primary completion: Feb 28, 2024 Completion: Feb 28, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Thalassemia, this trial is completed. The trial is conducted by Reem Ali Shaker and has accumulated 4 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Aug 2024 — Sep 2024 [monthly]

Completed

Status: Recruiting → Completed
Jul 2024 — Aug 2024 [monthly]

Recruiting
Feb 2024 — Jul 2024 [monthly]

Recruiting

First recorded

Mar 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Reem Ali Shaker

Data source: Kufa University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Najaf, Iraq